|
KIF2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.009600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.828800E-01 |
| Normal-vs-Stage2 |
4.154800E-01 |
| Normal-vs-Stage3 |
2.604600E-01 |
| Normal-vs-Stage4 |
8.789000E-01 |
| Stage1-vs-Stage2 |
4.579800E-01 |
| Stage1-vs-Stage3 |
2.112600E-01 |
| Stage1-vs-Stage4 |
8.855800E-01 |
| Stage2-vs-Stage3 |
7.652400E-01 |
| Stage2-vs-Stage4 |
5.168600E-01 |
| Stage3-vs-Stage4 |
4.365600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.245000E-01 |
| Normal-vs-AfricanAmerican |
5.574000E-01 |
| Normal-vs-Asian |
9.762600E-01 |
| Caucasian-vs-AfricanAmerican |
7.456400E-01 |
| Caucasian-vs-Asian |
8.728400E-01 |
| AfricanAmerican-vs-Asian |
8.199800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.041800E-01 |
| Normal-vs-Female |
1.016850E-03 |
| Male-vs-Female |
6.15979999999405E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.851200E-01 |
| Normal-vs-Extreme_Weight |
1.574970E-01 |
| Normal-vs-Obese |
1.172410E-01 |
| Normal-vs-Extreme_Obese |
4.641800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.973000E-01 |
| Normal_Weight-vs-Obese |
7.118000E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.727400E-01 |
| Extreme_Weight-vs-Obese |
1.107900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.159400E-01 |
| Obese-vs-Extreme_Obese |
2.097000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.242770E-01 |
| Normal-vs-Age(41-60Yrs) |
2.145600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.594200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.249800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.407400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.137180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.345500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.672200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.402300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.468300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.072000E-01 |
| Normal-VS-Type2 PRCC |
6.562400E-01 |
| Normal-VS-KIRP CIMP |
6.266200E-02 |
| Normal-VS-Unclassified PRCC |
2.251600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.655580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.444100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.595500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.634100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.830000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.958390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.223800E-01 |
| Normal-vs-N1 |
7.746400E-02 |
| Normal-vs-N2 |
5.464200E-01 |
| N0-vs-N1 |
3.296100E-02 |
| N0-vs-N2 |
2.493200E-01 |
| N1-vs-N2 |
8.021200E-01 |
|
|
